D
Diagnamed Holdings Corp.
DGNMF
$0.032
$0.0182131.88%
D
Sell
1/21/2025Upgraded
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 1/21/2025 due to an increase in the volatility index and total return index.
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 1/21/2025 due to an increase in the volatility index and total return index.
E
Sell
1/6/2025Downgrade
Diagnamed Holdings Corp. (DGNMF) was downgraded to E+ from D- on 1/6/2025 due to a decline in the volatility index.
Diagnamed Holdings Corp. (DGNMF) was downgraded to E+ from D- on 1/6/2025 due to a decline in the volatility index.
D
Sell
12/20/2024Upgraded
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 12/20/2024 due to an increase in the volatility index.
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 12/20/2024 due to an increase in the volatility index.
E
Sell
9/18/2024Downgrade
Diagnamed Holdings Corp. (DGNMF) was downgraded to E+ from D- on 9/18/2024 due to a decline in the volatility index and total return index.
Diagnamed Holdings Corp. (DGNMF) was downgraded to E+ from D- on 9/18/2024 due to a decline in the volatility index and total return index.
D
Sell
9/3/2024Upgraded
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 9/3/2024 due to a noticeable increase in the growth index and valuation index. EBIT increased 39.26% from -$188 to -$114.2.
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 9/3/2024 due to a noticeable increase in the growth index and valuation index. EBIT increased 39.26% from -$188 to -$114.2.
E
Sell
6/27/2024Downgrade
Diagnamed Holdings Corp. (DGNMF) was downgraded to E+ from D- on 6/27/2024 due to a large decline in the growth index, volatility index and solvency index. Earnings per share declined from $0.0004 to -$0.0012, EBIT declined 73.11% from -$108.6 to -$188, and the quick ratio declined from 2 to 1.6.
Diagnamed Holdings Corp. (DGNMF) was downgraded to E+ from D- on 6/27/2024 due to a large decline in the growth index, volatility index and solvency index. Earnings per share declined from $0.0004 to -$0.0012, EBIT declined 73.11% from -$108.6 to -$188, and the quick ratio declined from 2 to 1.6.
D
Sell
5/29/2024Upgraded
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 5/29/2024 due to a noticeable increase in the volatility index.
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 5/29/2024 due to a noticeable increase in the volatility index.
E
Sell
5/14/2024Downgrade
Diagnamed Holdings Corp. (DGNMF) was downgraded to E+ from D- on 5/14/2024 due to a noticeable decline in the volatility index and total return index.
Diagnamed Holdings Corp. (DGNMF) was downgraded to E+ from D- on 5/14/2024 due to a noticeable decline in the volatility index and total return index.
D
Sell
4/25/2024Upgraded
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 4/25/2024 due to a large increase in the growth index and volatility index. Earnings per share increased from -$0.0028 to $0.0004, EBIT increased 35.55% from -$168.5 to -$108.6, and operating cash flow increased 35.3% from -$161.2 to -$104.3.
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 4/25/2024 due to a large increase in the growth index and volatility index. Earnings per share increased from -$0.0028 to $0.0004, EBIT increased 35.55% from -$168.5 to -$108.6, and operating cash flow increased 35.3% from -$161.2 to -$104.3.
E
Sell
2/6/2024Downgrade
Diagnamed Holdings Corp. (DGNMF) was downgraded to E+ from D- on 2/6/2024 due to a substantial decline in the volatility index, growth index and solvency index. Earnings per share declined from -$0.0018 to -$0.0028, the quick ratio declined from 2.32 to 1.55, and EBIT declined 15.57% from -$145.8 to -$168.5.
Diagnamed Holdings Corp. (DGNMF) was downgraded to E+ from D- on 2/6/2024 due to a substantial decline in the volatility index, growth index and solvency index. Earnings per share declined from -$0.0018 to -$0.0028, the quick ratio declined from 2.32 to 1.55, and EBIT declined 15.57% from -$145.8 to -$168.5.
D
Sell
2/1/2024Upgraded
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 02/01/2024.
Diagnamed Holdings Corp. (DGNMF) was upgraded to D- from E+ on 02/01/2024.
E
Sell
11/1/2023Upgraded
Diagnamed Holdings Corp. (DGNMF) was upgraded to E+ from E on 11/1/2023 due to a large increase in the growth index, total return index and solvency index. Earnings per share increased from -$0.0041 to -$0.0018, and EBIT increased 52.37% from -$306.1 to -$145.8.
Diagnamed Holdings Corp. (DGNMF) was upgraded to E+ from E on 11/1/2023 due to a large increase in the growth index, total return index and solvency index. Earnings per share increased from -$0.0041 to -$0.0018, and EBIT increased 52.37% from -$306.1 to -$145.8.
E
Sell
7/26/2023None
Diagnamed Holdings Corp. (DGNMF) was downgraded to E from U on 07/26/2023.
Diagnamed Holdings Corp. (DGNMF) was downgraded to E from U on 07/26/2023.
OTC PK
03/12/2025 11:27AM Eastern
Quotes delayed
